Next Article in Journal
Consensus Statements among European Sleep Surgery Experts on Snoring and Obstructive Sleep Apnea: Part 1 Definitions and Diagnosis
Next Article in Special Issue
Reverse Septal Movement: A Step Forward in the Comprehension of the Underlying Causes
Previous Article in Journal
Tone Decay Reconsidered: Preliminary Results of a Prospective Study in Hearing-Aid Users with Moderate to Severe Hearing Loss
Previous Article in Special Issue
Non-Invasive Cardiac Output Measurement Using Inert Gas Rebreathing Method during Cardiopulmonary Exercise Testing—A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 13
Issue 2
10.3390/jcm13020501
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication

by
Raffaella Mistrulli
*,
Armando Ferrera
,
Melwyn Luis Muthukkattil
,
Allegra Battistoni
,
Giovanna Gallo
,
Emanuele Barbato
,
Francesco Raffaele Spera
and
Damiano Magrì
Clinical and Molecular Medicine Department, Sapienza University of Rome, 00185 Rome, Italy
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(2), 501; https://doi.org/10.3390/jcm13020501
Submission received: 6 November 2023 / Revised: 11 January 2024 / Accepted: 15 January 2024 / Published: 16 January 2024
(This article belongs to the Special Issue (Cardio-)Vascular System in Health and Disease: Current Update and Perspectives—Volume II)
Browse Figures
Versions Notes

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in patients affected by cardiomyopathies. Reports estimate a prevalence of 27% in patients with hypertrophic cardiomyopathy (HCM) and 40% in patients with cardiac amyloidosis (CA). The presence of AF typically results in progressive functional decline, an increased frequency of hospitalizations for heart failure, and a higher thromboembolic risk. Medical management using mainly beta-blockers or amiodarone has produced variable outcomes and a high rate of recurrence. Catheter ablation reduces symptom burden and complications despite a moderate rate of recurrence. Recent evidence suggests that an early rhythm control strategy may lead to more favorable short- and long-term outcomes. In this review, we summarize contemporary data on the management of AF in patients with cardiomyopathy (HCM and CA) with particular reference to the timing and outcomes of ablation procedures.
Keywords: atrial fibrillation; hypertrophic cardiomyopathy; cardiac amyloidosis; catheter ablatio atrial fibrillation; hypertrophic cardiomyopathy; cardiac amyloidosis; catheter ablatio

Share and Cite

MDPI and ACS Style

Mistrulli, R.; Ferrera, A.; Muthukkattil, M.L.; Battistoni, A.; Gallo, G.; Barbato, E.; Spera, F.R.; Magrì, D. Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication. J. Clin. Med. 2024, 13, 501. https://doi.org/10.3390/jcm13020501

AMA Style

Mistrulli R, Ferrera A, Muthukkattil ML, Battistoni A, Gallo G, Barbato E, Spera FR, Magrì D. Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication. Journal of Clinical Medicine. 2024; 13(2):501. https://doi.org/10.3390/jcm13020501

Chicago/Turabian Style

Mistrulli, Raffaella, Armando Ferrera, Melwyn Luis Muthukkattil, Allegra Battistoni, Giovanna Gallo, Emanuele Barbato, Francesco Raffaele Spera, and Damiano Magrì. 2024. "Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication" Journal of Clinical Medicine 13, no. 2: 501. https://doi.org/10.3390/jcm13020501

APA Style

Mistrulli, R., Ferrera, A., Muthukkattil, M. L., Battistoni, A., Gallo, G., Barbato, E., Spera, F. R., & Magrì, D. (2024). Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication. Journal of Clinical Medicine, 13(2), 501. https://doi.org/10.3390/jcm13020501

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop